Literature DB >> 1685359

Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30).

G Holmgren1, L Steen, J Ekstedt, C G Groth, B G Ericzon, S Eriksson, O Andersen, I Karlberg, G Nordén, M Nakazato.   

Abstract

Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant inherited disorder characterized by progressive peripheral and autonomic neuropathy, associated with neural and systemic amyloid deposits. The amyloid fibrils contain a variant transthyretin (TTR) molecule (TTR met30), over 90% of which is produced in the liver. After liver transplantation in two patients with severe symptomatic FAP, only normal TTR was detectable in circulation. The two patients are being monitored at regular intervals, and, although in one patient there was no evidence of reduction in the quantity of amyloid present at 6 months, there had been no further progression of the neuropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685359     DOI: 10.1111/j.1399-0004.1991.tb03085.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  71 in total

Review 1.  Amyloidosis.

Authors:  M F Khan; R H Falk
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

2.  Primary biliary cirrhosis and systemic amyloidosis, a new association.

Authors:  Hector Rodriguez-Luna; Hugo E Vargas; James Williams; Giovanni De Petris; Jorge Rakela; David D Douglas
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

3.  Combined cardiac and liver transplantation for the treatment of familial amyloidosis.

Authors:  Brian G Schwartz; Johannes J Kuiper; Göran B Klintmalm; Marvin J Stone; Jeffrey M Schussler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04

4.  Ten-year follow-up of peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation.

Authors:  Yoshio Shimojima; Hiroshi Morita; Sachio Kobayashi; Yo-ichi Takei; Shu-ichi Ikeda
Journal:  J Neurol       Date:  2008-05-20       Impact factor: 4.849

5.  Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial.

Authors:  Peter J Dyck; John C Kincaid; P James B Dyck; Vinay Chaudhry; Namita A Goyal; Christina Alves; Hayet Salhi; Janice F Wiesman; Celine Labeyrie; Jessica Robinson-Papp; Márcio Cardoso; Matilde Laura; Katherine Ruzhansky; Andrea Cortese; Thomas H Brannagan; Julie Khoury; Sami Khella; Márcia Waddington-Cruz; João Ferreira; Annabel K Wang; Marcus V Pinto; Samar S Ayache; Merrill D Benson; John L Berk; Teresa Coelho; Michael Polydefkis; Peter Gorevic; David H Adams; Violaine Plante-Bordeneuve; Carol Whelan; Giampaolo Merlini; Stephen Heitner; Brian M Drachman; Isabel Conceição; Christopher J Klein; Morie A Gertz; Elizabeth J Ackermann; Steven G Hughes; Michelle L Mauermann; Rito Bergemann; Karen A Lodermeier; Jenny L Davies; Rickey E Carter; William J Litchy
Journal:  Muscle Nerve       Date:  2017-04-07       Impact factor: 3.217

6.  [What gnaws at the heart and gets on the nerves].

Authors:  Arnt V Kristen
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

Review 7.  Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.

Authors:  A Hesse; K Altland; R P Linke; M R Almeida; M J Saraiva; A Steinmetz; B Maisch
Journal:  Br Heart J       Date:  1993-08

8.  Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.

Authors:  Teresa Coelho; Luis F Maia; Ana Martins da Silva; Marcia Waddington Cruz; Violaine Planté-Bordeneuve; Pierre Lozeron; Ole B Suhr; Josep M Campistol; Isabel Maria Conceição; Hartmut H-J Schmidt; Pedro Trigo; Jeffery W Kelly; Richard Labaudinière; Jason Chan; Jeff Packman; Amy Wilson; Donna R Grogan
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 9.  Novel drugs targeting transthyretin amyloidosis.

Authors:  Mazen Hanna
Journal:  Curr Heart Fail Rep       Date:  2014-03

10.  Recent advances in the treatment of familial amyloid polyneuropathy.

Authors:  David Adams
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.